Related Experiment Videos
Tumor-targeted cell killing with 8-hydroxyquinolyl-glucuronide
K J Henle1, T P Monson, W A Nagle
1Department of Medicine, University of Arkansas for Medical Sciences, Little Rock.
Radiation Research
|August 1, 1988
Summary
Elevated beta-glucuronidase in RIF-1 tumors suggests a novel cancer therapy. Targeting this enzyme with 8-hydroxyquinoline (8-OHQ) glucuronides may enhance drug delivery and efficacy for improved tumor treatment.
Area of Science:
- Biochemistry
- Oncology
- Pharmacology
Background:
- Tumors often exhibit elevated hydrolytic enzyme levels, potentially linked to invasive processes.
- The RIF-1 murine tumor model displays significantly higher beta-glucuronidase activity compared to liver tissue.
- Elevated tumor beta-glucuronidase presents a therapeutic target for enzyme-activated prodrug strategies.
Purpose of the Study:
- To investigate the potential of targeting elevated beta-glucuronidase in RIF-1 tumors using 8-hydroxyquinoline (8-OHQ) as a model compound.
- To evaluate the efficacy of systemically administered 8-hydroxyquinolyl-glucuronide for tumor-specific drug release and cytotoxicity.
- To explore combination therapies involving 8-OHQ, hyperthermia, and X-radiation for enhanced anti-tumor effects.
Main Methods:
- Assessed beta-glucuronidase activity in RIF-1 tumors and liver tissue of C3H mice.
- Quantified phenolphthalein release from its glucuronide in RIF tumors versus liver.
- Performed in vitro cytotoxicity assays using 8-OHQ and 8-hydroxyquinolyl-glucuronide on RIF tumor cells.
- Investigated the effects of combining 8-OHQ with hyperthermia or X-radiation on RIF tumor cell survival.
Main Results:
- RIF-1 tumors exhibited substantially higher beta-glucuronidase activity than liver tissue, releasing significantly more phenolphthalein from its glucuronide.
- Low concentrations of 8-OHQ (1-10 microM) demonstrated potent in vitro cytotoxicity against RIF tumor cells.
- 8-hydroxyquinolyl-glucuronide showed only modest cytotoxicity, indicating limited prodrug activation at the tested concentration.
- Combination treatments of 8-OHQ with hyperthermia or X-radiation did not significantly alter RIF tumor cell survival curves in vitro.
Conclusions:
- Elevated beta-glucuronidase in RIF-1 tumors provides a basis for targeted prodrug therapy.
- While 8-hydroxyquinolyl-glucuronide showed limited direct cytotoxicity, the concept of targeted 8-OHQ delivery is promising.
- Further in vivo studies are warranted to explore the therapeutic potential of combining targeted 8-OHQ delivery with local hyperthermia and/or irradiation for enhanced cancer treatment.